Zydus Wellness: Business Overview & Financial Analysis
Zydus Wellness is a leading consumer wellness and FMCG enterprise headquartered in Ahmedabad, Gujarat. Promoted by the Zydus Family (Zydus Lifesciences Group), the company manufactures, markets, and distributes iconic healthcare and wellness brands across consumer categories. Operating through an integrated national supply chain, Zydus Wellness manages flagship brands including Everyuth, Sugar Free, Nycil, Complan, Glucon-D, and Nutralite across domestic retail, e-commerce, and global export channels.
Brand Portfolio & Market Share of Zydus Wellness (FY26)
Zydus Wellness maintains market leadership across key personal care, healthcare, and nutrition categories in India.
- Sugar Free – 95.5% Market Share (#1 Position in Sugar Substitutes)
- Everyuth Peel Off Mask – 78.2% Market Share (#1 Position in Peel Off Category)
- Everyuth Scrub – 42.5% Market Share (#1 Position in Facial Scrubs)
- Glucon-D – 58.5% Market Share (#1 Position in Glucose Powder Category)
- Nycil – 34.2% Market Share (#1 Position in Prickly Heat Powder)
- Complan – #5 Position in Health Food Drinks (HFD) Segment
The brand portfolio features market-leading positions across sugar substitutes, skin scrubs, glucose powders, and cooling talcum powders. Sugar Free holds near-monopoly leadership with a 95.5% domestic market share, while Glucon-D and Everyuth scrub dominate their respective consumer categories.
Product Category Revenue Breakdown of Zydus Wellness (FY26)
Zydus Wellness categorises its operational turnover across personal care, food & nutrition, and health drink categories.
- Food & Nutrition Segment (Glucon-D, Complan, Sugar Free, Nutralite) – 82.5% of Total Operating Revenue
- Personal Care Segment (Everyuth, Nycil) – 17.5% of Total Operating Revenue
- Total Consolidated Revenue from Operations (FY26) – Rs 2,480.50 crore (+9.2% YoY)
The Food & Nutrition division serves as the primary top-line anchor, generating over four-fifths of total operating turnover. Personal Care brands provide seasonal sales acceleration during summer and monsoon retail cycles.
Distribution Network & Geographic Presence of Zydus Wellness (Q4 FY26)
Zydus Wellness distributes its consumer products through a multi-tier distribution network covering direct retail and modern trade channels.
- Direct Retail Coverage Reach – 2.85 million retail touchpoints across India
- Direct Channel Distribution Scale – 600,000+ direct retail stores
- International Export Presence – Supply footprint across 25+ countries in SAARC, MEA, and SEA regions
- E-Commerce & Quick-Commerce Sales Contribution – 11.5% of Total FMCG Revenue
- E-Commerce Channel Growth – +38.0% YoY growth in Q4 FY26
Direct retail coverage spans 2.85 million touchpoints, with direct distribution servicing 600,000 stores across urban and rural centers. E-commerce and quick-commerce platforms represent an accelerating delivery channel, accounting for 11.5% of total sales dispatches.
Manufacturing Infrastructure & Facilities Network of Zydus Wellness (FY26)
Zydus Wellness operates five manufacturing complexes in India equipped with automated processing and packaging lines.
- Operational Manufacturing Plants Base – 5 manufacturing facilities across 4 states
- Key Plant Locations – Aligarh (Uttar Pradesh), Sitarganj (Uttarakhand), Sikkim (2 plants), and Ahmedabad (Gujarat)
- Primary Processing Capabilities – Dairy processing, spray drying, powder blending, tubes filling, and formulation tableting
- Regulatory Standards – FSSAI, ISO 22000, and cGMP compliant manufacturing sites
Manufacturing plants in Aligarh and Sitarganj handle bulk processing for Complan and Glucon-D, while Sikkim facilities produce Everyuth personal care items. Integrated packaging lines support internal quality controls and unit cost efficiency.
Latest Quarterly Financial Performance of Zydus Wellness (Q4 FY26)
Zydus Wellness recorded top-line revenue expansion and operating profit growth during the fourth quarter of FY26.
- Consolidated Revenue from Operations – Rs 785.40 crore (+11.8% YoY)
- Consolidated Operating EBITDA – Rs 162.50 crore (+15.2% YoY)
- Operating EBITDA Margin – 20.69% (+61 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 138.20 crore (+18.5% YoY)
- Board Recommended Final Dividend – Rs 6.00 per equity share
Fourth-quarter operating revenue rose 11.8% year-on-year to Rs 785.40 crore, supported by early summer seasonal dispatches of Glucon-D and Nycil. Consolidated Net Profit After Tax reached Rs 138.20 crore, while operating EBITDA margins expanded to 20.69%.
Consolidated Annual Financial Performance of Zydus Wellness (FY26)
Zydus Wellness delivered full-year turnover expansion and net profitability growth for full financial year FY26.
- Full Year Consolidated Revenue from Operations – Rs 2,480.50 crore (+9.2% YoY)
- Full Year Operating EBITDA – Rs 385.20 crore (+12.8% YoY)
- Full Year Operating EBITDA Margin – 15.53% (+50 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 312.40 crore (+15.8% YoY)
- Return on Capital Employed (ROCE) – 14.2%
Full-year operating turnover crossed Rs 2,480 crore in FY26, as consolidated Net Profit After Tax expanded 15.8% to Rs 312.40 crore. Operational execution was supported by product realisations, quick-commerce volume growth, and raw material cost optimization.
Balance Sheet Leverage & Financial Health Ratios of Zydus Wellness (Q4 FY26)
Zydus Wellness maintains a low-debt capital structure supported by strong operating cash generation and working capital management.
- Debt to Equity Ratio – Net Cash Positive / Low Debt (0.04x)
- Consolidated Net Debt Outstanding – Rs 120 crore (reduced from Rs 280 crore in FY25)
- Net Debt to Operating EBITDA Ratio – 0.31x
- Cash, Bank Balances & Liquid Investments – Rs 450 crore
- Return on Equity (ROE) – 11.8%
Consolidated net debt compressed to Rs 120 crore at the close of Q4 FY26, bringing the Net Debt to EBITDA ratio down to 0.31x. Strong operating cash flows funded annual maintenance outlays while maintaining liquidity buffers.
New Product Launches & R&D Innovation Pipeline of Zydus Wellness (FY26)
Zydus Wellness accelerates product innovation to introduce health-oriented consumer line extensions across core brands.
- New Product Launches Revenue Share – ~8.5% of Total Turnover derived from innovations launched in last 36 months
- Sugar Free Line Extensions – Sugar Free Green (Stevia-based natural sweetener) and Sugar Free D'Lite Chocolates
- Nutralite Category Expansion – Nutralite Choco Spread, Nutralite Mayonnaise, and Premium Spreads
- Complan Innovations – Complan NutriGro and low-sugar variant formats for modern retail
- Everyuth Innovations – Body lotions, aloe vera gels, and specialized sheet masks
Product innovations contribute 8.5% of annual turnover, driven by natural sweetener variants and specialized Nutralite food spreads. R&D centers focus on zero-sugar formulations and plant-based personal care products.
Strategic Outlook & Management Commentary of Zydus Wellness (Q4 FY26)
Management guidance outlines strategic priorities centered on volume growth acceleration, distribution deepening, and margin protection.
- Management targets achieving high single-digit volume growth and double-digit revenue growth in FY27.
- Operating EBITDA margins are guided to sustain within the 16.0%–17.5% corridor through operating leverage.
- Direct retail distribution is targeted to expand to 800,000 stores over the next 2 years.
- International export revenue share is projected to reach 8%–10% of total turnover by FY28.
- Capital allocation will prioritize brand building, quick-commerce expansion, and debt reduction via internal cash flows.
Management anticipates domestic FMCG demand and quick-commerce channels to drive volume growth across core categories. Operational focus remains on expanding direct retail distribution, accelerating new product launches, and protecting operating margins.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Zydus Wellness Q4 & Full Year FY26 Consolidated Financial Results Disclosures (May 2026)
- Zydus Wellness Q4 FY26 Investor Presentation & Fact Sheet (May 2026)
- BSE India & NSE Official Corporate Announcements for Zydus Wellness
- Ticker Finology Zydus Wellness Page
Disclaimer
The information presented above on Zydus Wellness has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Zydus Wellness page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.